✦ LIBER ✦

Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis: A randomized multicenter controlled trial

✍ Scribed by Christophe Moreno; Philippe Langlet; Axel Hittelet; Luc Lasser; Delphine Degré; Sylvie Evrard; Isabelle Colle; Arnaud Lemmers; Jacques Devière; Olivier Le Moine

Book ID: 116652210
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 807 KB
Volume: 53
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2010.05.030

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Short- and Long-Term Outcome of Severe A

Short- and Long-Term Outcome of Severe Alcohol-Induced Hepatitis Treated With Steroids or Enteral Nutrition: A Multicenter Randomized Trial

✍ Eduard Cabré; Pilar Rodrı́guez-Iglesias; Joan Caballerı́a; Joan C. Quer; José L. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

83 TREATMENT OF SEVERE ACUTE ALCOHOLIC H

83 TREATMENT OF SEVERE ACUTE ALCOHOLIC HEPATITIS (AAH) WITH CORTICOIDS PLUS N-ACETYL CYSTEINE (C+NAC) VERSUS CORTICOIDS ALONE (C): A MULTICENTRE, RANDOMIZED, CONTROLLED TRIAL

✍ E. Nguyen-Khac; T. Thevenot; M.-A. Piquet; S. Benferhat; O. Goria; D. Chatelain; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 52 KB

38 TREATMENT OF SEVERE ACUTE ALCOHOLIC H

38 TREATMENT OF SEVERE ACUTE ALCOHOLIC HEPATITIS (AAH) WITH CORTICOIDS PLUS N-ACETYL CYSTEINE (C-NAC) VERSUS CORTICOIDS (C): PLANED INTERIM ANALYSIS OF A MULTICENTRE, CONTROLLED, RANDOMIZED TRIAL

✍ E. Nguyen-Khac; T. Thevenot; M.A. Piquet; D. Chatelain; B. Tramier; F. Dewael; S 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 62 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder

✍ Lesley M. Arnold; Amy Rosen; Yili Lu Pritchett; Deborah N. D'Souza; David J. Gol 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 265 KB

A phase II randomized, double-blind, pla

A phase II randomized, double-blind, placebo-controlled multicenter study of recombinant human interleukin-12 for the treatment of chronic hepatitis C virus infection in patients non-responsive to previous treatment with interferon-alpha with or without ribavirin: Paul J Pockros, John G McHutchison, Scripps Clinic, La Jolla, CA; Chris O'Brien, University of Miami, Miami, FL; Myron Tong, Huntingon Medical Research Institute, Pasadena, CA; Coleman Smith, Minnesota Clinical Research Center, St. Paul, MN; Vinod Rustgi, Metropolitan Research Group, Fairfax, VA; Robert L Carithers, University of Washington Medical Center, Seattle, WA; Elizabeth Olek, Genetics Institute, Cambridge, MA

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB